MICROALBUMINURIA AND MINERALS
PRIMUM NON NOCERE INDUSTRIEUX
Versandkostenfrei!
Versandfertig in 1-2 Wochen
25,99 €
inkl. MwSt.
PAYBACK Punkte
13 °P sammeln!
Nephropathy in the diabetic patient follows a well-established course, beginning with microalbuminuria, progressing to proteinuria, hyperazotemia and culminating in end-stage renal failure. Early nephropathy has also been shown to predict vision-threatening retinal disease in patients with type 1 diabetes. Chronic hyperglycemia is a key factor in microangiopathy because of its rate, duration and likely mediators. The hypothesis of a relationship between the angiotensin-1 converting enzyme gene and the deleterious effects of chronic hyperglycemia is possible through an insertion/deletion polymo...
Nephropathy in the diabetic patient follows a well-established course, beginning with microalbuminuria, progressing to proteinuria, hyperazotemia and culminating in end-stage renal failure. Early nephropathy has also been shown to predict vision-threatening retinal disease in patients with type 1 diabetes. Chronic hyperglycemia is a key factor in microangiopathy because of its rate, duration and likely mediators. The hypothesis of a relationship between the angiotensin-1 converting enzyme gene and the deleterious effects of chronic hyperglycemia is possible through an insertion/deletion polymorphism which in fact influences the frequency of serious cardiac complications in insulin-dependent patients with diabetic nephropathy, a situation characterized by high plasma angiotensin converting enzyme concentrations. This chronic hyperglycemia is related to the poorly understood angiotensin II. Experimentally, growth hormone and insulin like-growth factors, through a complex system, may be responsible for the changes.
Andere Kunden interessierten sich für
